These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19722699)

  • 1. Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization.
    Waxman EA; Mazzulli JR; Giasson BI
    Biochemistry; 2009 Oct; 48(40):9427-36. PubMed ID: 19722699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence Determinants for Amyloid Fibrillogenesis of Human alpha-Synuclein.
    Zibaee S; Jakes R; Fraser G; Serpell LC; Crowther RA; Goedert M
    J Mol Biol; 2007 Nov; 374(2):454-64. PubMed ID: 17936783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E46K mutation in alpha-synuclein increases amyloid fibril formation.
    Greenbaum EA; Graves CL; Mishizen-Eberz AJ; Lupoli MA; Lynch DR; Englander SW; Axelsen PH; Giasson BI
    J Biol Chem; 2005 Mar; 280(9):7800-7. PubMed ID: 15632170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.
    Ulrih NP; Barry CH; Fink AL
    Biochim Biophys Acta; 2008 Oct; 1782(10):581-5. PubMed ID: 18692132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.
    Boyer DR; Li B; Sun C; Fan W; Sawaya MR; Jiang L; Eisenberg DS
    Nat Struct Mol Biol; 2019 Nov; 26(11):1044-1052. PubMed ID: 31695184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
    Bodles AM; Guthrie DJ; Harriott P; Campbell P; Irvine GB
    Eur J Biochem; 2000 Apr; 267(8):2186-94. PubMed ID: 10759841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the aggregation of an amyloidogenic alpha-synuclein peptide fragment.
    Madine J; Doig AJ; Kitmitto A; Middleton DA
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1113-5. PubMed ID: 16246058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
    Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
    Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of alpha-synuclein neurodegeneration.
    Waxman EA; Giasson BI
    Biochim Biophys Acta; 2009 Jul; 1792(7):616-24. PubMed ID: 18955133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
    Candreva J; Chau E; Rice ME; Kim JR
    Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM structure of alpha-synuclein fibrils.
    Guerrero-Ferreira R; Taylor NM; Mona D; Ringler P; Lauer ME; Riek R; Britschgi M; Stahlberg H
    Elife; 2018 Jul; 7():. PubMed ID: 29969391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy.
    Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X
    Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.
    Cohlberg JA; Li J; Uversky VN; Fink AL
    Biochemistry; 2002 Feb; 41(5):1502-11. PubMed ID: 11814343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy.
    Flynn JD; McGlinchey RP; Walker RL; Lee JC
    J Biol Chem; 2018 Jan; 293(3):767-776. PubMed ID: 29191831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the acidic domain of α-synuclein in amyloid fibril formation: a molecular dynamics study.
    Park S; Yoon J; Jang S; Lee K; Shin S
    J Biomol Struct Dyn; 2016; 34(2):376-83. PubMed ID: 25869255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.
    Moriarty GM; Olson MP; Atieh TB; Janowska MK; Khare SD; Baum J
    J Biol Chem; 2017 Sep; 292(39):16368-16379. PubMed ID: 28710275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A; Ahn KJ; Kim J; Carver JA
    Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.